Achondroplasia is the most common form of skeletal dysplasia or dwarfism, affecting around one in 20,000 babies in Australia. The genetic condition can cause serious medical complications such as ...

Kyowa Kirin will develop the product for the treatment of achondroplasia, hypochondroplasia and other skeletal dysplasias. BridgeBio is currently conducting a Phase 3 global study of the drug in ...